Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000050045 | SCV000957659 | pathogenic | Cohen syndrome | 2018-10-29 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111). This variant has been observed in individuals affected with Cohen syndrome (PMID: 17990063). ClinVar contains an entry for this variant (Variation ID: 56632). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu3709Serfs*61) in the VPS13B gene. It is expected to result in an absent or disrupted protein product. |
Fulgent Genetics, |
RCV000050045 | SCV002797994 | pathogenic | Cohen syndrome | 2022-05-17 | criteria provided, single submitter | clinical testing | |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000050045 | SCV000082454 | probable-pathogenic | Cohen syndrome | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |